Ipamorelin vs Tesamorelin
A ghrelin-receptor secretagogue against a GHRH analogue — two mechanisms often combined in growth-hormone research.
How they actually differ
Different receptors, complementary roles. Tesamorelin acts at the GHRH receptor to prompt growth-hormone release; Ipamorelin acts at the ghrelin receptor to do so through a separate pathway with minimal effect on cortisol or appetite. They are studied together as often as compared. Both are water-soluble and refrigerated after mixing; Ipamorelin is the more forgiving of the two, with no oxidation-prone residues at all.
Ipamorelin — origin
Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH2) is a pentapeptide ghrelin-receptor agonist. It was characterised as the first highly selective growth-hormone secretagogue — prompting GH release with minimal effect on cortisol, prolactin or appetite signalling, which is the property that keeps it in the research literature.
Tesamorelin — origin
Tesamorelin is the complete 44-amino-acid sequence of human growth hormone-releasing hormone with a trans-3-hexenoic acid group attached at the N-terminus. That modification exists for one reason: native GHRH is cleaved almost immediately by dipeptidyl peptidase-4 at the N-terminal end, and the hexenoyl group blocks that cleavage.
Ipamorelin research themes
Studied as a selective GHS-R agonist that releases GH with little effect on cortisol, prolactin or ACTH — the feature that distinguishes it from earlier GHRPs.
Examined for the shape and timing of growth-hormone release in research models.
Frequently combined with GHRH analogues such as CJC-1295 to study two GH-release pathways at once.
Tesamorelin research themes
Full-length GHRH activity with DPP-4 resistance conferred by the N-terminal modification.
The most distinctive endpoint in its research literature.
Studied for effects on endogenous GH secretion patterns rather than direct GH substitution.
Investigated alongside body-composition endpoints in metabolic research.
Ipamorelin handling
- Reach room temperature before opening.
- Swirl to dissolve; the peptide clears in seconds.
- Label aliquots with reconstitution date and diluent.
Tesamorelin handling
- Allow several minutes for dissolution; do not accelerate with agitation or heat.
- Swirl gently — long chains aggregate at interfaces.
- Do not freeze reconstituted solution.
Both third-party tested
Every Popular Peptides batch of Ipamorelin and Tesamorelin is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.
Ipamorelin reference
Related comparisons
Ipamorelin and Tesamorelin are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.